6.
Wang X, Keith Jr J, Struthers A, Feuerstein G
. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. Cardiovasc Ther. 2008; 26(3):214-23.
DOI: 10.1111/j.1755-5922.2008.00051.x.
View
7.
Cheng H, Ye Z, Chiou K, Lin S, Charng M
. Vascular stiffness in familial hypercholesterolaemia is associated with C-reactive protein and cholesterol burden. Eur J Clin Invest. 2007; 37(3):197-206.
DOI: 10.1111/j.1365-2362.2007.01772.x.
View
8.
Touboul P, Hennerici M, Meairs S, Adams H, Amarenco P, Bornstein N
. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2006; 23(1):75-80.
DOI: 10.1159/000097034.
View
9.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M
. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33):3021-3104.
DOI: 10.1093/eurheartj/ehy339.
View
10.
Hovingh G, Davidson M, Kastelein J, OConnor A
. Diagnosis and treatment of familial hypercholesterolaemia. Eur Heart J. 2013; 34(13):962-71.
DOI: 10.1093/eurheartj/eht015.
View
11.
Plana N, Ferre R, Merino J, Aragones G, Girona J, Heras M
. Heterozygous familial hypercholesterolaemic patients have increased arterial stiffness, as determined using the augmentation index. J Atheroscler Thromb. 2011; 18(12):1110-6.
DOI: 10.5551/jat.9795.
View
12.
Arroyo L, Lee R
. Mechanisms of plaque rupture: mechanical and biologic interactions. Cardiovasc Res. 1999; 41(2):369-75.
DOI: 10.1016/s0008-6363(98)00308-3.
View
13.
Tonstad S, Joakimsen O, Stensland-Bugge E, Ose L, Bonaa K, Leren T
. Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects. Eur J Clin Invest. 1999; 28(12):971-9.
DOI: 10.1046/j.1365-2362.1998.00399.x.
View
14.
Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W
. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47.
DOI: 10.1161/01.cir.97.18.1837.
View
15.
Giallauria F, Milaneschi Y, Tanaka T, Maggio M, Canepa M, Elango P
. Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. J Clin Endocrinol Metab. 2012; 97(10):3717-23.
PMC: 3674293.
DOI: 10.1210/jc.2012-1584.
View
16.
Smilde T, van den Berkmortel F, Wollersheim H, van Langen H, Kastelein J, Stalenhoef A
. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia. Eur J Clin Invest. 2000; 30(6):473-80.
DOI: 10.1046/j.1365-2362.2000.00654.x.
View
17.
Mattina A, Giammanco A, Giral P, Rosenbaum D, Carrie A, Cluzel P
. Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: The role of cholesterol burden and gender. Nutr Metab Cardiovasc Dis. 2019; 29(10):1068-1076.
DOI: 10.1016/j.numecd.2019.06.015.
View
18.
Scioli M, Storti G, DAmico F, Rodriguez Guzman R, Centofanti F, Doldo E
. Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets. J Clin Med. 2020; 9(6).
PMC: 7355625.
DOI: 10.3390/jcm9061995.
View
19.
Spina R, Noto D, Barbagallo C, Monastero R, Ingrassia V, Valenti V
. Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred. J Clin Lipidol. 2017; 12(1):145-151.
DOI: 10.1016/j.jacl.2017.10.014.
View
20.
Gallo A, de Isla L, Charriere S, Vimont A, Alonso R, Muniz-Grijalvo O
. The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia. JACC Cardiovasc Imaging. 2021; 14(12):2414-2424.
DOI: 10.1016/j.jcmg.2021.06.011.
View